BERETTA, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 6.959
EU - Europa 3.116
AS - Asia 1.737
SA - Sud America 63
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 4
OC - Oceania 4
Totale 11.895
Nazione #
US - Stati Uniti d'America 6.861
CN - Cina 640
SG - Singapore 628
IT - Italia 566
SE - Svezia 545
DE - Germania 500
RU - Federazione Russa 420
IE - Irlanda 376
UA - Ucraina 234
HK - Hong Kong 189
GB - Regno Unito 173
FI - Finlandia 104
CA - Canada 91
VN - Vietnam 78
FR - Francia 61
IN - India 61
ID - Indonesia 59
BR - Brasile 52
TR - Turchia 38
BE - Belgio 31
NL - Olanda 31
DK - Danimarca 29
CZ - Repubblica Ceca 15
IR - Iran 14
AT - Austria 6
EU - Europa 6
A2 - ???statistics.table.value.countryCode.A2??? 5
CL - Cile 5
KR - Corea 5
AU - Australia 4
DO - Repubblica Dominicana 4
JP - Giappone 4
BD - Bangladesh 3
BG - Bulgaria 3
ES - Italia 3
GR - Grecia 3
MX - Messico 3
UZ - Uzbekistan 3
AR - Argentina 2
CH - Svizzera 2
CI - Costa d'Avorio 2
HR - Croazia 2
IQ - Iraq 2
KG - Kirghizistan 2
MD - Moldavia 2
MY - Malesia 2
RO - Romania 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
EC - Ecuador 1
EE - Estonia 1
IL - Israele 1
KW - Kuwait 1
LU - Lussemburgo 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 11.895
Città #
Ann Arbor 1.285
Woodbridge 617
Chandler 608
Singapore 504
Fairfield 480
Houston 446
Dublin 367
Ashburn 353
Frankfurt am Main 352
Jacksonville 287
Santa Clara 283
Wilmington 241
Seattle 204
Dearborn 202
New York 200
Hong Kong 185
Cambridge 177
Princeton 165
Milan 154
Hangzhou 121
Shanghai 93
Beijing 79
Boardman 79
Altamura 76
Nanjing 76
Lawrence 65
Jakarta 53
Dong Ket 51
Lachine 49
Helsinki 48
San Diego 44
Mountain View 34
Shenyang 33
Brussels 29
Fremont 29
Nanchang 28
Guangzhou 26
Andover 25
Hebei 24
London 21
Toronto 20
Dallas 18
Falls Church 18
Villeurbanne 16
Changsha 15
Jiaxing 14
Lissone 14
Rome 14
Zhengzhou 14
Carate Brianza 13
Norwalk 13
Tianjin 13
Munich 12
Hefei 11
Jinan 11
Los Angeles 11
Lentate sul Seveso 10
Pune 10
Grafing 9
São Paulo 9
Washington 9
Kunming 8
Ningbo 8
Ottawa 8
San Mateo 8
Brno 7
Chicago 7
Huizen 7
Monza 7
Sacramento 7
Zanjan 7
Amsterdam 6
Moscow 6
Padova 6
Capoterra 5
Kocaeli 5
Lanzhou 5
Leawood 5
Legnano 5
Olomouc 5
Taizhou 5
Turin 5
Assago 4
Auburn Hills 4
Capralba 4
Catania 4
Como 4
Groningen 4
Haikou 4
Kilburn 4
Lyon 4
Montréal 4
Nürnberg 4
Redwood City 4
Samaná 4
Tappahannock 4
University Park 4
Vienna 4
Winnipeg 4
Angers 3
Totale 8.670
Nome #
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 314
Incidence and predictors of acute symptomatic seizures after stroke 269
The role of clinical and neuroimaging features in the diagnosis of CADASIL 257
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 251
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 246
Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment 244
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 222
Multicentre translational Trial of Remote Ischaemic Conditioning in Acute Ischaemic Stroke (TRICS): protocol of multicentre, parallel group, randomised, preclinical trial in female and male rat and mouse from the Italian Stroke Organization (ISO) Basic Science network 222
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 220
Guillain-Barré syndrome related to COVID-19 infection 220
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 216
Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease 200
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 199
Intracranial collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 190
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 186
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 180
Headache in cerebral venous thrombosis associated with extracranial tumors: a clinical series 178
Clinical factors associated with statins prescription in acute ischemic stroke patients: Findings from the Lombardia Stroke Registry 178
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 174
Case Report: Concomitant Massive Cerebral Venous Thrombosis and Internal Iliac Vein Thrombosis Related to Paucisymptomatic COVID-19 Infection 174
Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: the ICARO study 172
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage 169
The THRombolysis and STatins (THRaST) study 169
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 167
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 167
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 166
Experimental in-vivo model of intravascular shunting for neurosurgical bypass 161
Topographical and morphological patterns of post reperfusion molecular penumbra 158
Neurological outcome of postanoxic refractory status epilepticus after aggressive treatment 154
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 153
Therapeutic modulation of intracranial collateral flow improves outcome in experimental ischemic stroke 151
Intracranial Collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 151
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage 148
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: The ICARO-2 study 148
Prognostic patterns and predictors in epilepsy: A multicentre study (PRO-LONG) 147
SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy 146
Intracranial collateral flow in experimental ischemic stroke. From hemodynamic monitoring to collateral therapeutics 145
Enhanced recovery strategies in colorectal surgery: is the compliance with the whole program required to achieve the target? 144
Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke 144
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 141
Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke 138
Thermal plantar test in experimental ischemic stroke 138
Guillain–Barré Syndrome Associated with COVID-19 135
Pharmacological manipulation of glutamate transport 133
Comprehensive educational plan for patients with epilepsy and comorbidity (EDU-COM): A pragmatic randomised trial 132
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 131
Cerebral collateral circulation in experimental ischemic stroke 127
Elevated peripheral leukocyte counts in acute cervical artery dissection 126
Brain ultrasound rehearsal before surgery: A pilot cadaver study 126
Absence and reappearance of N20 response after thiopental withdrawal in postanoxic coma 125
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 123
Optimized system for cerebral perfusion monitoring in the rat stroke model of intraluminal middle cerebral artery occlusion 122
Peripheral markers of glutamatergic dysfunction in neurological disease: focus on ex vivo tools 117
Association of vascular risk factors with cervical artery dissection and ischemic stroke in young adults 114
Pathogenesis of retinal ganglion cell death in Leber hereditary optic neuropathy (LHON): possible involvement of mitochondria, light and glutamate 112
Possible neuroprotective strategies in ALS 112
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 112
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 109
Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke 109
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 108
Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network 106
Current Developments in Stroke: vol 1 New Concepts in Stroke Diagnosis and Therapy 102
From observation to monitoring: implementation of quantitative electroencephalography (QEEG) in neurointensive care 101
Thrombolysis in Cervical Artery Dissection - Data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database 99
Cervical artery dissection in patients ≥60 years Often painless, few mechanical triggers 99
Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patients 87
Double antiglutamatergic therapy in a case of postanoxic super-refractory status epilepticus 86
Efficacy and safety of perampanel oral loading in postanoxic super-refractory status epilepticus: A pilot study 85
Spectral properties of the EEG during recovery of consciousness after acute brain injury 83
Quantitative EEG interpretation by EEG-naïve neurointensivists before and after expert training 82
Chapter 16. Impact of COVID-19 on pre-existing neurological diseases 82
Combined administration of memantine and chlomethiazole is very effective at preventing excitotoxic-induced cell death in cultured retinal and cerebellar granule neurons 79
Quantitative EEG in NICU. An Easily Interpretable Tool for the Intensivist? 79
From observation to monitoring: implementation of quantitative electroencephalography (QEEG) in neurointensive care 79
Treatment of Transiently Symptomatic Acute Internal Carotid Artery Occlusion: Learning from the Interventional Field 77
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 77
L'approccio multidisciplinare nella sclerosi laterale amiotrofica 74
Multi-Center Randomized Phase II Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies (TRICS-9): Study Design and Protocol 73
Determinants and outcome of multiple and early recurrent cervical artery dissections 72
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 72
Peripheral markers of oxidative stress and excitotoxicity in neurodegenerative disorders: tools for diagnosis and therapy? 69
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 68
Guillain-Barré syndrome AMSAN variant in a 90-year-old woman after COVID-19: a case report 45
Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission 35
Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients with COVID-19 Infected with Pre-Omicron Variants 34
Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke 27
The state of stroke services across the globe: Report of World Stroke Organization–World Health Organization surveys 25
Genetic Risk Score for Intracranial Aneurysms: Prediction of Subarachnoid Hemorrhage and Role in Clinical Heterogeneity 25
Head down positioning before recanalization in acute ischemic stroke 25
Editorial: Remote Ischemic Conditioning (Pre, Per, and Post) as an Emerging Strategy of Neuroprotection in Ischemic Stroke 25
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 24
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 22
Predictors of delayed stroke in patients with cervical artery dissection 22
Primary stroke prevention worldwide: translating evidence into action 21
Neurovascular and infectious disease phenotype of acute stroke patients with and without COVID-19 21
EFFICACY AND SAFETY OF PERAMPANEL ORAL LOADING IN POST-ANOXIC SUPER-REFRACTORY STATUS EPILEPTICUS: A CASE SERIES 20
Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in Italy 20
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 20
Reperfusion by endovascular thrombectomy and early cerebral edema in anterior circulation stroke: Results from the SITS-International Stroke Thrombectomy Registry 19
Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL) 19
Totale 12.170
Categoria #
all - tutte 47.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020975 0 0 0 0 0 217 234 110 147 103 120 44
2020/20211.657 137 63 160 178 127 174 145 132 121 192 75 153
2021/20221.290 108 128 145 84 97 92 51 49 73 107 140 216
2022/20232.108 247 667 196 207 111 312 19 119 124 8 58 40
2023/20241.639 37 36 73 101 178 357 339 43 161 13 56 245
2024/20251.711 243 448 201 182 413 224 0 0 0 0 0 0
Totale 12.461